Insider Trading activities of Regeneron Pharmaceuticals Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Regeneron Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Regeneron Pharmaceuticals Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Regeneron Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is REGN. The reporting company's CIK number is 872589.
The total value of stock buying since 2005 is $2,475,753,844.
The total value of stock sales since 2005 is $1,068,888,188.
The total value of stock option exercises since 2005 is $284,711,527.



Table 2. Detailed insider stock purchases, sales, and option exercises of Regeneron Pharmaceuticals Inc insiders (REGN) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-02-20 Ryan Arthur F (Director) Option Ex 29,250 135.50 3,963,521
2015-02-20 Brown Michael S (Director) Sale 1,000 422.72 422,720
2015-02-20 Brown Michael S (Director) Option Ex 1,000 57.11 57,110
2015-02-17 Aberman Michael S (SVP Strategy Investor Relation) Sale 3,692 404.02 1,491,641
2015-02-13 Aberman Michael S (SVP Strategy Investor Relation) Option Ex 7,500 24.00 180,000
2015-01-02 Powchik Peter (SVP Clinical Development & Reg) Sale 10,822 414.71 4,487,948
2015-01-02 Schleifer Leonard S (President & CEO) Sale 1,500 411.75 617,625
2014-12-31 Powchik Peter (SVP Clinical Development & Reg) Option Ex 25,000 52.03 1,300,750
2014-12-24 Sanofi Buy 30,002 396.41 11,893,032
2014-12-23 Sanofi Buy 171,457 391.47 67,119,585
2014-12-19 Powchik Peter (SVP Clinical Development & Reg) Option Ex 3,264 30.63 99,976
2014-12-18 Van Plew Daniel P (SVP & General Mgr Industrial O) Option Ex 3,264 30.63 99,976
2014-12-17 Mccorkle Douglas S (VP Controller and Asst Treasur) Option Ex 2,800 30.63 85,764
2014-12-16 Mccorkle Douglas S (VP Controller and Asst Treasur) Sale 6,818 410.00 2,795,380
2014-12-16 Mccorkle Douglas S (VP Controller and Asst Treasur) Option Ex 6,818 41.33 281,787
2014-12-16 Yancopoulos George (President Regeneron Laboratori) Option Ex 3,264 30.63 99,976
2014-12-16 Stahl Neil (SVP Research and Development S) Option Ex 3,264 30.63 99,976
2014-12-16 Goldberg Murray A (SVP Administration & Asst Secr) Option Ex 3,264 30.63 99,976
2014-12-15 Mccorkle Douglas S (VP Controller and Asst Treasur) Sale 1,668 412.65 688,305
2014-12-15 Mccorkle Douglas S (VP Controller and Asst Treasur) Option Ex 1,668 30.63 51,090
2014-11-25 Poon Christine A (Director) Buy 400 410.00 164,000
2014-11-24 Stahl Neil (SVP Research and Development S) Sale 2,200 409.90 901,790
2014-11-24 Gilman Alfred G (Director) Sale 40,000 408.44 16,337,800
2014-11-24 Gilman Alfred G (Director) Option Ex 40,000 38.31 1,532,520
2014-11-21 Stahl Neil (SVP Research and Development S) Sale 3,107 415.16 1,289,902
2014-11-18 Terifay Robert J (SVP Commercial) Sale 22,362 404.71 9,050,147
2014-11-18 Stahl Neil (SVP Research and Development S) Option Ex 16,757 115.29 1,931,914
2014-11-17 Terifay Robert J (SVP Commercial) Option Ex 48,750 21.25 1,035,937
2014-11-13 Van Plew Daniel P (SVP & General Mgr Industrial O) Sale 8,575 399.58 3,426,398
2014-11-12 Van Plew Daniel P (SVP & General Mgr Industrial O) Option Ex 18,700 21.25 397,375
2014-11-12 Goldstein Joseph L (Director) Sale 5,000 398.31 1,991,550
2014-11-12 Goldstein Joseph L (Director) Option Ex 5,000 177.82 889,100
2014-11-12 Schleifer Leonard S (President & CEO) Sale 42,324 400.67 16,957,957
2014-11-11 Schleifer Leonard S (President & CEO) Sale 3,493 400.00 1,397,200
2014-10-31 Schleifer Leonard S (President & CEO) Sale 3,453 400.11 1,381,579
2014-10-28 Schleifer Leonard S (President & CEO) Sale 69,112 405.45 28,021,598
2014-10-27 Schleifer Leonard S (President & CEO) Option Ex 256,808 158.01 40,578,232
2014-10-24 Goldberg Murray A (SVP Administration & Asst Secr) Sale 26,788 400.06 10,716,807
2014-10-24 Brown Michael S (Director) Sale 5,000 399.00 1,995,000
2014-10-24 Brown Michael S (Director) Option Ex 5,000 57.11 285,550
2014-10-23 Goldberg Murray A (SVP Administration & Asst Secr) Option Ex 60,000 30.63 1,837,800
2014-10-16 Sanofi Buy 122,127 334.12 40,804,828
2014-10-15 Sanofi Buy 158,368 329.35 52,157,867
2014-09-16 Sanofi Buy 31,717 348.94 11,067,171
2014-09-15 Sanofi Buy 80,824 343.90 27,795,454
2014-09-12 Sanofi Buy 59,808 346.50 20,723,172
2014-09-10 Vagelos P Roy (Chairman of the Board) Sale 10,326 350.07 3,614,822
2014-09-08 Vagelos P Roy (Chairman of the Board) Sale 2 351.00 702
2014-08-27 Tessier-lavigne Marc (Director) Sale 3,000 352.20 1,056,600
2014-08-27 Tessier-lavigne Marc (Director) Option Ex 3,000 50.91 152,730
2014-08-27 Mccorkle Douglas S (VP Controller and Asst Treasur) Option Ex 1,681 25.94 43,605
2014-08-27 Yancopoulos George (President Regeneron Laboratori) Option Ex 5,720 314.31 1,797,853
2014-08-27 Goldstein Joseph L (Director) Sale 2,000 350.31 700,620
2014-08-26 Tessier-lavigne Marc (Director) Option Ex 1,387 50.91 70,612
2014-08-26 Vagelos P Roy (Chairman of the Board) Option Ex 303,909 11.64 3,537,500
2014-08-22 Aberman Michael S (VP Strategy and Investor Relat) Option Ex 3,000 24.00 72,000
2014-08-19 Aberman Michael S (VP Strategy and Investor Relat) Sale 3,611 350.00 1,263,850
2014-08-18 Aberman Michael S (VP Strategy and Investor Relat) Option Ex 8,750 52.03 455,262
2014-08-18 Mccorkle Douglas S (VP Controller and Asst Treasur) Sale 5,875 353.00 2,073,875
2014-08-18 Mccorkle Douglas S (VP Controller and Asst Treasur) Option Ex 5,875 52.03 305,676
2014-08-15 Brown Michael S (Director) Sale 3,000 349.20 1,047,600
2014-08-15 Brown Michael S (Director) Option Ex 3,000 33.42 100,260
2014-08-11 Stahl Neil (SVP Research and Development S) Sale 11,646 340.21 3,962,120
2014-08-11 Vagelos P Roy (Chairman of the Board) Sale 9,372 340.52 3,191,353
2014-08-08 Stahl Neil (SVP Research and Development S) Sale 2,100 340.80 715,680
2014-08-08 Vagelos P Roy (Chairman of the Board) Sale 2,600 340.33 884,858
2014-08-07 Van Plew Daniel P (SVP & General Mgr Industrial O) Sale 6,806 338.37 2,302,946
2014-08-07 Stahl Neil (SVP Research and Development S) Sale 741 340.71 252,466
2014-08-07 Vagelos P Roy (Chairman of the Board) Option Ex 270,352 9.49 2,565,640
2014-08-06 Van Plew Daniel P (SVP & General Mgr Industrial O) Option Ex 15,000 21.25 318,750
2014-08-06 Stahl Neil (SVP Research and Development S) Option Ex 35,000 21.25 743,750
2014-08-06 Goldstein Joseph L (Director) Sale 2,000 331.20 662,400
2014-07-15 Sanofi Buy 129,100 315.06 40,674,246
2014-07-14 Sanofi Buy 150,000 317.06 47,558,250
2014-07-11 Sanofi Buy 150,000 315.10 47,264,850
2014-07-10 Sanofi Buy 175,000 310.54 54,343,800
2014-07-09 Sanofi Buy 195,000 307.80 60,021,000
2014-07-08 Sanofi Buy 153,000 312.20 47,766,447
2014-07-07 Sanofi Buy 256,700 313.46 80,464,411
2014-07-03 Sanofi Buy 100,000 311.20 31,120,000
2014-07-02 Sanofi Buy 212,400 305.58 64,905,616
2014-07-01 Sanofi Buy 212,400 295.93 62,855,319
2014-06-30 Sanofi Buy 212,400 280.15 59,504,921
2014-06-27 Sanofi Buy 50,000 275.22 13,760,950
2014-05-23 Van Plew Daniel P (SVP & General Mgr Industrial O) Sale 5,369 296.01 1,589,304
2014-05-22 Van Plew Daniel P (SVP & General Mgr Industrial O) Option Ex 11,200 21.25 238,000
2014-05-21 Poon Christine A (Director) Buy 255 291.90 74,434
2014-05-19 Sanofi Buy 190,751 299.45 57,119,623
2014-03-28 Sanofi Buy 306,945 307.76 94,466,314
2014-03-27 Sanofi Buy 306,945 310.48 95,301,511
2014-03-24 Baker Charles A (Director) Sale 15,000 306.77 4,601,595
2014-03-24 Baker Charles A (Director) Option Ex 15,000 23.84 357,600
2014-03-24 Sanofi Buy 306,945 306.70 94,140,031
2014-03-21 Sanofi Buy 305,115 322.74 98,471,899
2014-03-20 Sanofi Buy 57,957 327.72 18,993,841
2014-03-19 Sanofi Buy 9,746 327.57 3,192,497
2014-03-17 Brown Michael S (Director) Sale 2,000 335.05 670,096
2014-03-17 Brown Michael S (Director) Option Ex 2,000 33.42 66,840
2014-03-17 Sanofi Buy 60,128 328.59 19,757,639
2014-03-14 Sanofi Buy 55,583 327.98 18,230,223
2014-03-12 Sanofi Buy 220,995 332.33 73,444,373
2014-03-11 Sanofi Buy 180,710 332.15 60,023,368
2014-03-10 Sanofi Buy 199,822 328.89 65,718,658
2014-03-07 Sanofi Buy 311,691 324.81 102,734,802
2014-03-06 Sanofi Buy 80,404 339.23 27,275,609
2014-03-03 Sanofi Buy 251,594 334.42 84,137,310
2014-02-27 Brown Michael S (Director) Sale 1,000 335.00 335,000
2014-02-27 Vagelos P Roy (Chairman of the Board) Option Ex 70,879 16.90 1,198,067
2014-02-26 Brown Michael S (Director) Option Ex 1,000 57.11 57,110
2014-02-25 Goldberg Murray A (SVP Administration & Asst Secr) Sale 11,871 341.22 4,050,575
2014-02-25 Goldstein Joseph L (Director) Sale 1,000 338.86 338,860
2014-02-24 Goldberg Murray A (SVP Administration & Asst Secr) Option Ex 30,227 77.39 2,339,267
2014-02-21 Goldberg Murray A (SVP Administration & Asst Secr) Sale 21,258 334.48 7,110,333
2014-02-21 Gilman Alfred G (Director) Sale 5,000 340.00 1,700,000
2014-02-21 Gilman Alfred G (Director) Option Ex 5,000 18.61 93,050
2014-02-21 Sing George L (Director) Sale 15,000 339.00 5,085,000
2014-02-21 Sing George L (Director) Option Ex 15,000 15.80 237,000
2014-02-20 Mccorkle Douglas S (VP Controller and Asst Treasur) Option Ex 3,000 21.25 63,750
2014-02-20 Goldberg Murray A (SVP Administration & Asst Secr) Option Ex 50,652 61.03 3,091,088
2014-02-20 Goldstein Joseph L (Director) Sale 1,000 327.09 327,090
2014-02-18 Aberman Michael S (VP Strategy and Investor Relat) Sale 3,648 329.79 1,203,055
2014-02-18 Terifay Robert J (SVP Commercial) Sale 12,865 332.73 4,280,610
2014-02-14 Aberman Michael S (VP Strategy and Investor Relat) Option Ex 7,500 30.63 229,725
2014-02-14 Terifay Robert J (SVP Commercial) Option Ex 27,795 21.25 590,643
2014-02-14 Sing George L (Director) Sale 15,000 324.00 4,860,000
2014-02-14 Sing George L (Director) Option Ex 15,000 9.17 137,550
2014-02-13 Stahl Neil (SVP Research and Development S) Sale 22,612 318.98 7,212,775
2014-02-12 Yancopoulos George (President Regeneron Laboratori) Sale 88,987 323.02 28,744,936
2014-02-12 Stahl Neil (SVP Research and Development S) Option Ex 54,548 18.28 997,301
2014-02-12 Goldstein Joseph L (Director) Sale 1,000 320.62 320,620
2014-02-12 Shooter Eric M (Director) Sale 15,000 320.81 4,812,225
2014-02-12 Shooter Eric M (Director) Option Ex 15,000 89.45 1,341,750
2014-02-11 Mccorkle Douglas S (VP Controller and Asst Treasur) Sale 5,819 325.00 1,891,175
2014-02-11 Mccorkle Douglas S (VP Controller and Asst Treasur) Option Ex 5,819 30.63 178,235
2014-02-11 Yancopoulos George (President Regeneron Laboratori) Option Ex 189,463 9.49 1,798,003
2014-02-11 Gilman Alfred G (Director) Sale 5,000 320.00 1,600,000
2014-02-11 Gilman Alfred G (Director) Option Ex 5,000 18.61 93,050
2014-02-11 Vagelos P Roy (Chairman of the Board) Sale 11,475 325.10 3,730,522
2014-02-07 Sanofi Buy 21,986 287.22 6,314,906
2014-02-06 Sanofi Buy 146,525 285.61 41,849,005
2014-02-05 Sanofi Buy 206,978 281.27 58,217,322
2014-02-04 Sanofi Buy 190,286 285.07 54,245,591
2014-02-03 Sanofi Buy 198,058 284.15 56,278,180
2014-01-31 Sanofi Buy 10,914 288.13 3,144,661
2014-01-28 Sanofi Buy 83,235 276.68 23,029,709
2014-01-27 Sanofi Buy 74,685 272.68 20,365,329
2014-01-14 Mccorkle Douglas S (VP Controller and Asst Treasur) Sale 4,000 290.00 1,160,000
2014-01-14 Gilman Alfred G (Director) Sale 5,000 300.00 1,500,000
2014-01-14 Gilman Alfred G (Director) Option Ex 5,000 18.61 93,050
2014-01-02 Powchik Peter (SVP Clinical Development & Reg) Sale 20,668 275.27 5,689,321

Insider trading activities including stock purchases, stock sales, and option exercises of REGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Regeneron Pharmaceuticals Inc (symbol REGN, CIK number 872589) see the Securities and Exchange Commission (SEC) website.